Article
Genome-wide Mendelian randomization and multi-omics integration identify drug targets for irritable bowel syndrome
2024-01-18
Abstract excerpt
<h4>Introduction: </h4> Irritable bowel syndrome (IBS) is a common chronic functional gastrointestinal disorder. Despite the intricate and varied range of symptoms, there are now no recognized effective therapeutic methods. Mendelian randomization (MR) is a commonly employed method for repurposing existing licensed medications and identifying novel therapeutic targets. Hence, our objective was to discover new trea...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cb3219d1-f5b3-5fbd-84f1-c6a48a722acc
- DOI
- 10.21203/rs.3.rs-3800640/v1
